Finance

Lists
002589:SHE
Realcan Pharmaceutical Group Co Ltd
CNÂ¥3.26
+0.62%
(+0.020) 1D
Oct 13, 3:04:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002589...
Open
CNÂ¥3.22
High
CNÂ¥3.27
Low
CNÂ¥3.10
Mkt. cap
4.88B
Avg. vol.
113.56M
Volume
74.80M
Dividend
0.06%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jun 30, 2026
P/E ratio
540.63
52-wk high
CNÂ¥4.69
52-wk low
CNÂ¥2.38
EPS
CNÂ¥0.01
Shares outstanding
1.50B
No. of employees
2K
Open
CNÂ¥3.22
High
CNÂ¥3.27
Low
CNÂ¥3.10
Mkt. cap
4.88B
Avg. vol.
113.56M
Volume
74.80M
Dividend
0.06%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jun 30, 2026
P/E ratio
540.63
52-wk high
CNÂ¥4.69
52-wk low
CNÂ¥2.38
EPS
CNÂ¥0.01
Shares outstanding
1.50B
No. of employees
2K
News stories
From web sources and news partners
About Realcan Pharmaceutical Group Co Ltd
CEO-
Employees2.41K
FoundedSep 21, 2004
Headquarters-
SectorHealth care provider
Websiterealcan.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.86B
1.89B
1.71B
1.71B
Cost of goods sold
1.61B
1.74B
1.49B
1.54B
Cost of revenue
1.61B
1.74B
1.49B
1.54B
Research and development expenses
5.31M
4.40M
2.71M
3.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
175.68M
128.25M
144.14M
143.12M
Operating expense
170.72M
175.33M
155.66M
141.50M
Total operating expenses
1.78B
1.92B
1.64B
1.68B
Operating income
79.41M
-29.77M
62.58M
25.97M
Other non operating income
-43.53M
-34.43M
-2.05M
22.05M
EBT including unusual items
19.93M
-1.86M
16.32M
21.74M
EBT excluding unusual items
22.05M
-2.72M
16.16M
21.73M
Income tax expense
23.53M
-18.76M
697.10K
7.03M
Effective tax rate
118.07%
1,009.59%
4.27%
32.32%
Other operating expenses
12.43M
8.46M
8.65M
8.20M
Net income
-6.03M
3.93M
10.37M
763.09K
Net profit margin
-0.32%
0.21%
0.61%
0.04%
Earnings per share
-
-
-
-
Interest and investment income
25.13M
83.49M
10.96M
14.56M
Interest expense
-38.96M
-22.01M
-55.32M
-40.85M
Net interest expenses
-13.83M
61.48M
-44.36M
-26.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
119.81M
7.54M
99.89M
56.35M
Gain or loss from assets sale
173.18K
-1.82M
-
-188.56K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps